Skip to main content
Explore URMC

URMC Logo

menu

2016 Publications

2018 | 2017 | 2016 | 2015 | 2014 | Archived

2016, Dec
Nogales A, Martínez-Sobrido L
Reverse Genetics Approaches for the Development of Influenza Vaccines.
PMID: 28025504

2016, Dec
Millet JK, Whittaker GR
Murine Leukemia Virus (MLV)-based Coronavirus Spike-pseudotyped Particle Production and Infection.
PMID: 28018942

2016, Dec
Lee J, Boutz DR, Chromikova V, Joyce MG, Vollmers C, Leung K, Horton AP, DeKosky BJ, Lee CH, Lavinder JJ, Murrin EM, Chrysostomou C, Hoi KH, Tsybovsky Y, Thomas PV, Druz A, Zhang B, Zhang Y, Wang L, Kong WP, Park D, Popova LI, Dekker CL, Davis MM, Carter CE, Ross TM, Ellington AD, Wilson PC, Marcotte EM, Mascola JR, Ippolito GC, Krammer F, Quake SR, Kwong PD, Georgiou G
Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination.
PMID: 27820605

2016, Oct
Lenartowicz E, Nogales A, Kierzek E, Kierzek R, Martínez-Sobrido L, Turner DH
Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication.
PMID: 27463680

2016, Oct
Lenartowicz E, Nogales A, Kierzek E, Kierzek R, Martínez-Sobrido L, Turner DH
Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication.
PMID: 27463680

2016, Oct
Neu KE, Henry Dunand CJ, Wilson PC
Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
PMID: 27268395

2016, Oct
He W, Tan GS, Mullarkey CE, Lee AJ, Lam MM, Krammer F, Henry C, Wilson PC, Ashkar AA, Palese P, Miller MS
Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
PMID: 27698132

2016, Oct
Hsu HL, Millet JK, Costello DA, Whittaker GR, Daniel S.
Viral fusion efficacy of specific H3N2 influenza virus reassortant combinations at single-particle level.
PMID: 27752100

2016, Oct
Romero-Beltran L, Baker SF, Puerto-Solís M, González-Losa R, Conde-Ferraez L, Alvarez-Sánchez LC, Martínez-Sobrido L, Ayora-Talavera G
Mutations at highly conserved residues in influenza A(H1N1)pdm09 virus affect neuraminidase activity.
PMID: 27596738

2016, Oct
Millet JK, Goldstein ME, Labitt RN, Hsu HL, Daniel S, Whittaker GR
A camel-derived MERS-CoV with a variant spike protein cleavage site and distinct fusion activation properties.
PMID: 27999426

2016, Sept
Millet JK, Séron K, Labitt RN, Danneels A, Palmer KE, Whittaker GR, Dubuisson J, Belouzard S
Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin.
PMID: 27424494

2016, Sept
Sun X, Hu F, Wu S, Qiu X, Linel P, Wu H
Controllability and stability analysis of large transcriptomic dynamic systems for host response to influenza infection in human.
PMID: 29928721

2016, Sept
Carey M, Wu S, Gan G, Wu H
Correlation-based iterative clustering methods for time course data: The identification of temporal gene response modules for influenza infection in humans.
PMID: 29928719

2016, Aug
Wang K, Langevin S, O'Hern CS, Shattuck MD, Ogle S, Forero A, Morrison J, Slayden R, Katze MG, Kirby M
Anomaly Detection in Host Signaling Pathways for the Early Prognosis of Acute Infection.
PMID: 27532264

2016, Aug
DeDiego ML, Nogales A, Lambert-Emo K, Martinez-Sobrido L, Topham DJ
An NS1 protein mutation (I64T) affects interferon responses and virulence of circulation H3N2 human influenza A viruses
PMID: 27535054

2016, Aug
Anderson CS, DeDiego ML, Thakar J, Topham DJ.
Novel Sequence-Based Mapping of Recently Emerging H5NX Influenza Viruses Reveals Pandemic Vaccine Candidates.
PMID: 27494186

2016, July
Hayashi T, Chaimayo C, McGuinness J, Takimoto T
Critical Role of the PA-X C-Terminal Domain of Influenza A Virus in Its Subcellular Localization and Shutoff Activity.
PMID: 27226377

2016, June
Henry Dunand CJ, Leon PE, Huang M, Choi A, Chromikova V, Ho IY, Tan GS, Cruz J, Hirsh A, Zheng NY, Mullarkey CE, Ennis FA, Terajima M, Treanor JJ, Topham DJ, Subbarao K, Palese P, Krammer F, Wilson PC.
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.
PMID: 27281570

2016, June
Jiang T, Nogales A, Baker SF, Martinez-Sobrido L, Turner DH
Mutations Designed by Ensemble Defect to Misfold Conserved RNA Structures of Influenza A Segments 7 and 8 Affect Splicing and Attenuate Viral Replication in Cell Culture.
PMID: 27272307

2016, June
Jiang T, Nogales A, Baker SF, Martinez-Sobrido L, Turner DH
Mutations Designed by Ensemble Defect to Misfold Conserved RNA Structures of Influenza A Segments 7 and 8 Affect Splicing and Attenuate Viral Replication in Cell Culture.
PMID: 27272307

2016, June
Nogales A, DeDiego ML, Topham DJ, Martínez-Sobrido L
Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.
PMID: 27122587

2016, June
Breen M, Nogales A, Baker SF, Martínez-Sobrido L
Replication-Competent Influenza A Viruses Expressing Reporter Genes.
PMID: 27347991

2016, June
DiPiazza A, Richards K, Batarse F, Lockard L, Zeng H, García-Sastre A, Albrecht RA, Sant AJ.
Flow Cytometric and Cytokine ELISpot Approaches to Characterize the Cell-mediated Immune Response in Ferrets Following Influenza Virus Infection.
PMID: 27356897

2016, June
Knowlden ZA, Sant AJ.
CD4 T cell epitope specificity determines follicular versus non-follicular helper differentiation in the polyclonal response to influenza infection or vaccination.
PMID: 27329272

2016, Mar
Rappazzo CG, Watkins HC, Guarino CM, Chau A, Lopez JL, DeLisa MP, Leifer CA, Whittaker GR, Putnam D
Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.
PMID: 26827663

2016, Mar
White JM, Whittaker GR.
Fusion of Enveloped Viruses in Endosomes.
PMID: 26935856

2016, Feb
Roldán JS, Martínez MG, Forlenza MB, Whittaker GR, Candurra NA
Human transferrin receptor triggers an alternative Tacaribe virus internalization pathway.
PMID: 26559962

2016, Feb
Anderson CS, DeDiego ML, Topham DJ, Thakar J.
Boolean modeling of Cellular and Molecular pathways involved in Influenza Infection.
PMID: 26981147

2016, Feb
Tisoncik-Go J, Gasper DJ, Kyle JE, Eisfeld AJ, Selinger C, Hatta M, Morrison J, Korth MJ, Zink EM, Kim YM, Schepmoes AA, Nicora CD, Purvine SO, Weitz KK, Peng X, Green RR, Tilton SC, Webb-Robertson BJ, Waters KM, Metz TO, Smith RD, Kawaoka Y, Suresh M, Josset L, Katze MG.
Integrated omics analysis of host responses during pandemic H1N1 influenza infection.
PMID: 26867183

2016, Feb
Nogales A, Rodríguez-Sánchez I, Monte K, Lenschow DJ, Perez DR, Martínez-Sobrido L
Replication-competent fluorescent-expressing influenza B virus.
PMID: 26590325

2016, Feb
DeDiego ML, Anderson CS, Yang H, Holden-Wiltse J, Fitzgerald T, Treanor JJ, Topham DJ.
Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine mediated immune protection.
PMID: 26854888

2016, Jan
Breen M, Nogales A, Baker SF, Perez DR, Martínez-Sobrido L
Replication-Competent Influenza A and B Viruses Expressing a Fluorescent Dynamic Timer Protein for In Vitro and In Vivo Studies.
PMID: 26809059

2016, Jan
DiPiazza A, Richards KA, Knowlden ZA, Nayak JL, Sant AJ.
The Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of Influenza.
PMID: 26834750